Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

A. Marchesi, I. Tarissi De Jacobis, D. Rigante, A. Rimini, W. Malorni, G. Corsello, G. Bossi, S. Buonuomo, F. Cardinale, E. Cortis, F. De Benedetti, A. De Zorzi, M. Duse, D. Del Principe, R.M. Dellepiane, L. D'Isanto, M. El Hachem, S. Esposito, F. Falcini, U. GiordanoM.C. Maggio, S. Mannarino, G. Marseglia, S. Martino, G. Marucci, R. Massaro, C. Pescosolido, D. Pietraforte, M.C. Pietrogrande, P. Salice, A. Secinaro, E. Straface, A. Villani

Research output: Contribution to journalArticle

Abstract

This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications. © 2018 The Author(s).
Original languageEnglish
JournalItalian Journal of Pediatrics
Volume44
Issue number1
DOIs
Publication statusPublished - 2018

Keywords

  • anakinra
  • apixaban
  • canakinumab
  • clopidogrel
  • dabigatran
  • fondaparinux
  • hydroxymethylglutaryl coenzyme A reductase inhibitor
  • infliximab
  • low molecular weight heparin
  • methylprednisolone
  • prednisone
  • rivaroxaban
  • tissue plasminogen activator
  • warfarin
  • immunoglobulin
  • nonsteroid antiinflammatory agent, abdominal pain
  • adrenal cortex insufficiency
  • anaphylaxis
  • angioneurotic edema
  • arthralgia
  • atherosclerosis
  • bleeding
  • bradycardia
  • bronchospasm
  • cardiovascular disease
  • cardiovascular risk
  • cataract
  • chorioretinopathy
  • congestive heart failure
  • coronary artery aneurysm
  • coronary artery thrombosis
  • diabetes mellitus
  • diarrhea
  • digestive system perforation
  • disease classification
  • disease severity
  • dizziness
  • drug efficacy
  • drug mechanism
  • dysphagia
  • eosinophilia
  • erythema
  • face edema
  • fatigue
  • fitness
  • follow up
  • gastrointestinal hemorrhage
  • gastrointestinal symptom
  • glaucoma
  • hand edema
  • headache
  • heart arrhythmia
  • heart surgery
  • heart transplantation
  • human
  • hyperglycemia
  • hypersensitivity
  • hypertension
  • hypertransaminasemia
  • hypocalcemia
  • hypotension
  • hypothermia
  • hypovolemic shock
  • infection
  • influenza
  • information dissemination
  • intracranial hypertension
  • invasive procedure
  • lifestyle
  • liver failure
  • malaise
  • mucocutaneous lymph node syndrome
  • myalgia
  • myopathy
  • nausea
  • neutropenia
  • osteoporosis
  • pain
  • pancreatitis
  • pediatrician
  • Perthes disease
  • physician
  • plasmapheresis
  • pneumonia
  • practice guideline
  • pruritus
  • rash
  • Review
  • rhinitis
  • rhinopharyngitis
  • seizure
  • shock
  • sinusitis
  • skin bruising
  • thrombocytopenia
  • thrombosis
  • thrombotic thrombocytopenic purpura
  • treatment contraindication
  • treatment indication
  • upper respiratory tract infection
  • urticaria
  • vomiting
  • child
  • coronary artery disease
  • drug resistance
  • female
  • male
  • medical society
  • pediatrics
  • preschool child
  • risk assessment
  • severity of illness index, Anti-Inflammatory Agents, Non-Steroidal
  • Cardiovascular Diseases
  • Child
  • Child, Preschool
  • Coronary Artery Disease
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous
  • Male
  • Mucocutaneous Lymph Node Syndrome
  • Pediatrics
  • Practice Guidelines as Topic
  • Risk Assessment
  • Severity of Illness Index
  • Societies, Medical

Fingerprint Dive into the research topics of 'Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks'. Together they form a unique fingerprint.

Cite this